...
首页> 外文期刊>Journal of neurology >Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.
【24h】

Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.

机译:严重残疾的恶性多发性硬化患者中,脉冲环磷酰胺后自体造血干细胞移植。

获取原文
获取原文并翻译 | 示例
           

摘要

Multiple sclerosis (MS) may run a rapidly progressive monophasic course (the Marburg, or malignant form), that carries a poor prognosis [1]. Autologous hematopoietic stem cell transplant (AHSCT), initially utilised in chronic MS [2], is now occasionally administered in acute aggressive relapsing-remitting MS (RRMS) [3]. We describe a case of malignant-type MS treated with pulsed cyclophosphamide (CY) and non-myeloablative AHSCT. A 21-year-old woman, presented with sensorimotor disturbance to all four limbs in April 2011. Neuro-imaging demonstrated demyelination with enhancement (Fig. la), cerebrospinal fluid (CSF) demonstrated 47 lymphocytes and was positive for oligoclonal bands. Serum was negative for aquporin4 (Aq4) antibodies. Three days of 1 g IV methylprednisolone (IVMP) failed to slow progression. A second course of IVMP 5 weeks later was unsuccessful, as were seven sessions of plasma exchange undertaken over a 2-week period and the patient became tetraplegic.
机译:多发性硬化症(MS)可能会进行快速进展的单相病程(马尔堡或恶性形式),预后较差[1]。自体造血干细胞移植(AHSCT),最初用于慢性MS [2],现在偶尔用于急性侵袭性复发-缓解MS(RRMS)[3]。我们描述了一例用脉冲环磷酰胺(CY)和非清髓性AHSCT治疗的恶性型MS。一名21岁妇女于2011年4月对所有四个肢体表现出感觉运动障碍。神经影像检查显示脱髓鞘增强(图1a),脑脊液(CSF)显示47个淋巴细胞,寡克隆带阳性。血清对aquporin4(Aq4)抗体阴性。 3天的1 g静脉注射甲基强的松龙(IVMP)未能减缓病情。 5周后第二次IVMP疗程未成功,在两周内进行了七次血浆置换,患者变为四瘫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号